Загрузка...
Lebrikizumab in the personalized management of asthma
There is a need for improved therapies for severe asthma. Lebrikizumab, a humanized monoclonal antibody that binds to interleukin (IL)-13, is under development for the treatment of poorly controlled asthma. This article reviews the potential role of IL-13 in the pathogenesis of asthma, the efficacy...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3459551/ https://ncbi.nlm.nih.gov/pubmed/23055690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S28666 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|